NCT01712997 Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients Status UNKNOWN Phase PHASE3
NCT01662037 Bosentan Therapy in Children With Functional Single Ventricle Status COMPLETED Phase PHASE2
NCT01617746 Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma Status UNKNOWN Phase PHASE2
NCT01518595 Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis Status TERMINATED Phase PHASE2
NCT01449253 Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia Status UNKNOWN Phase PHASE4
NCT01447550 Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan Status COMPLETED Phase N/A
NCT01425229 Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin Status COMPLETED Phase N/A
NCT01392469 Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants Status COMPLETED Phase PHASE3
NCT01357109 Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT01352065 Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration Status COMPLETED Phase PHASE2/PHASE3
NCT01292551 Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology. Status COMPLETED Phase PHASE2
NCT01223352 Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension Status COMPLETED Phase PHASE3
NCT01218607 Bosentan for Mild Pulmonary Vascular Disease in Asd Patients. Status COMPLETED Phase PHASE3
NCT01184404 Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery Status UNKNOWN Phase NA
NCT01100736 Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3) Status COMPLETED Phase EARLY_PHASE1